Fisher Asset Management LLC Sells 1,082 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Fisher Asset Management LLC lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,391 shares of the company’s stock after selling 1,082 shares during the period. Fisher Asset Management LLC’s holdings in GE HealthCare Technologies were worth $318,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its position in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares during the period. Fred Alger Management LLC acquired a new position in shares of GE HealthCare Technologies in the second quarter valued at about $26,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the third quarter worth about $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $31,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Stifel Nicolaus upped their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.46.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $83.22 on Monday. The company’s 50 day moving average price is $87.78 and its two-hundred day moving average price is $83.64. The firm has a market capitalization of $38.02 billion, a P/E ratio of 22.86, a P/E/G ratio of 2.98 and a beta of 1.24. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter last year, the business posted $0.99 EPS. GE HealthCare Technologies’s revenue for the quarter was up .9% on a year-over-year basis. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is currently 3.30%.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.